Cryo-Cell International Balance Sheet

Financials in millions USD. Fiscal year is December - November.

Millions USD. Fiscal year is Dec - Nov.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '25 Nov 30, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021
Cash & Equivalents	0.32	0.56	0.41	1.7	8.26
Short-Term Investments	2.98	2.94	0.57	0.02	0.08
Trading Asset Securities	-	-	0.12	-	-
Cash & Short-Term Investments	3.3	3.5	1.1	1.72	8.34
Cash Growth	-5.72%	217.15%	-35.97%	-79.35%	-20.20%
Receivables	6.85	7.31	6.58	6.04	5.25
Inventory	0.41	0.66	0.77	0.85	0.92
Prepaid Expenses	0.57	0.64	0.62	0.57	0.56
Other Current Assets	0.63	0.45	0.39	0.43	0.71
Total Current Assets	11.76	12.55	9.45	9.61	15.78
Property, Plant & Equipment	21.85	22.7	22.03	14.21	4.15
Long-Term Investments	-	-	0.31	0.31	0.31
Goodwill	1.94	1.94	1.94	1.94	1.94
Other Intangible Assets	0.86	0.92	0.99	15.15	16.21
Long-Term Deferred Tax Assets	23.62	20.8	20.49	13.74	12.01
Other Long-Term Assets	1.69	5.76	6.01	9.92	10.26
Total Assets	61.73	64.68	61.22	64.89	60.66
Accounts Payable	2.87	1.88	3.17	1.61	1.49
Accrued Expenses	4.28	4.39	3.74	3.24	3.06
Short-Term Debt	2.3	3.52	1.22	2.27	-
Current Portion of Long-Term Debt	0.18	0.17	0.17	0.15	1.9
Current Portion of Leases	0.43	0.43	0.23	0.3	0.31
Current Income Taxes Payable	-	1.42	1.43	0.34	-
Current Unearned Revenue	9.73	9.79	9.7	9.59	9.36
Other Current Liabilities	-	-	1.2	1.98	4.96
Total Current Liabilities	19.79	21.6	20.86	19.48	21.07
Long-Term Debt	8.17	8.31	8.43	8.58	-
Long-Term Leases	0.47	0.51	0.85	0.31	0.61
Long-Term Unearned Revenue	50.97	46.56	41.19	36	31.27
Other Long-Term Liabilities	0.92	0.92	0.92	2.04	3.52
Total Liabilities	80.33	77.89	72.25	66.41	56.48
Common Stock	0.15	0.15	0.15	0.15	0.15
Additional Paid-In Capital	44.71	44.27	43.41	42.6	41.59
Retained Earnings	-38.44	-32.78	-31.16	-21.64	-16.74
Treasury Stock	-25.03	-24.86	-23.43	-22.63	-20.81
Shareholders' Equity	-18.61	-13.22	-11.03	-1.52	4.18
Total Liabilities & Equity	61.73	64.68	61.22	64.89	60.66
Total Debt	11.56	12.93	10.9	11.61	2.82
Net Cash (Debt)	-8.26	-9.44	-9.79	-9.89	5.52
Net Cash Growth	-	-	-	-	31.08%
Net Cash Per Share	-1.02	-1.15	-1.17	-1.17	0.66
Filing Date Shares Outstanding	8.06	8.08	8.29	8.44	8.5
Total Common Shares Outstanding	8.06	8.08	8.29	8.5	8.56
Working Capital	-8.03	-9.04	-11.41	-9.87	-5.29
Book Value Per Share	-2.31	-1.64	-1.33	-0.18	0.49
Tangible Book Value	-21.41	-16.08	-13.96	-18.62	-13.97
Tangible Book Value Per Share	-2.66	-1.99	-1.68	-2.19	-1.63
Buildings	-	19.73	11.22	11.22	1.51
Machinery	-	5.97	8.75	7.74	6.84
Construction In Progress	-	-	6.71	-	-
Leasehold Improvements	-	1.23	1.26	1.26	1.21

Updated Nov 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q